En analyse med total mortalitet som sekundært endpoint viste ingen signifikant forskel mellem clopidogrel (5, 8%) og ASA (6, 0%).
Analysis of total mortality as a secondary endpoint did not show any significant difference between clopidogrel (5.8%) and ASA (6.0%).